The effectiveness of Fuzi in combination with routine heart failure treatment on chronic heart failure patients
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 289, 115040
Abstract
No abstract availableKeywords
Funding Information
- Taiwan Ministry of Science and Technology (108-2320-B-037-022 -MY3)
This publication has 28 references indexed in Scilit:
- A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart FailureJACC, 2013
- Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regenerationFrontiers in Genetics, 2013
- Dose‐response analyses using restricted cubic spline functions in public health researchStatistics in Medicine, 2010
- Toxicity Assessment of Nine Types of Decoction Pieces from the Daughter Root ofAconitum carmichaeli(Fuzi) Based on the Chemical Analysis of their Diester Diterpenoid AlkaloidsPlanta Medica, 2009
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Aconitum in Traditional Chinese Medicine—A valuable drug or an unpredictable risk?Journal of Ethnopharmacology, 2009
- Clinical features and management of herb-induced aconitine poisoningAnnals of Emergency Medicine, 2004
- A Practical Guide to Dose-Response Analyses and Risk Assessment in Occupational EpidemiologyEpidemiology, 2004
- Avoiding Power Loss Associated with Categorization and Ordinal Scores in Dose-Response and Trend AnalysisEpidemiology, 1995
- Depolarizing Neuromuscular Blocking Action of Coryneine Derived from Aconite Root in Isolated Mouse Phrenic Nerve-Diaphragm Muscles.Biological and Pharmaceutical Bulletin, 1995